This week’s Friday Five takes a look at some of the most notable medical, pharmaceutical and scientific breakthroughs of 2022.
Medical Innovation
Next Generation of mRNA Vaccinology
COVID-19 unlocked the power of mRNA Vaccines.
Medical Research Discoveries
Cedars-Sinai Research Helps Gain New Insights Into an Array of Diseases and Conditions
Investigators at Cedars-Sinai conduct more than 2,500 research projects annually, and many of these studies have resulted in new treatments or have opened the door to future innovations. Here are some of the most significant Cedars-Sinai research news from 2022, ranging from major advancements in understanding COVID-19 to the use of artificial intelligence for predicting and diagnosing diseases to revealing how the brain makes memories.
Ovarian Cancer – Identifying the Underlying Causes of Ovarian Cancer
Two new discoveries led by Cedars-Sinai Cancer investigators help improve the understanding of what drives the development of ovarian cancer and why some women’s tumors do not respond to therapy.
Pharma
FDA Approves First Drug That Can Delay Onset of Type 1 Diabetes
The U.S. Food and Drug Administration approved Tzield (teplizumab-mzwv) injection to delay the onset of stage 3 type 1 diabetes in adults and pediatric patients 8 years and older who currently have stage 2 type 1 diabetes.
Biomanufacturing
Manufacturing Stem Cells in Space
Already pioneers in regenerative medicine, scientists at Cedars-Sinai are launching their expertise into space to see if they can elevate the next generation of stem cell and gene therapies by harnessing the near-zero gravity conditions of spaceflight.
Science
One of the Biggest Problems in Biology Has Finally Been Solved
Google DeepMind (@deepmind) CEO Demis Hassabis explains how its AlphaFold AI program predicted the 3-D structure of every known protein.
ICYMI – Our other Friday Fives and Blog posts from HCNR’s Nurse Lauren.
